A Study to Assess the Relative Bioavailability of Three Immediate-Release Tablet Formulations of ABBV-903 in Healthy Adult Volunteers
NCT06078202
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Strategic considerations
Conditions
Healthy Volunteers
Interventions
DRUG:
ABBV-903
Sponsor
AbbVie